Table 4 : Three and five-year cause-specific survival rates (%) and confidence intervals for cases ≥40 years that were diagnosed
between  2000 and 2007 (SEER 17 southern and total states).


  SEER 17 Southern States
SEER 17 Total States

  N 3-year survival (CI) 5-year survival (CI) N 3-year  survival (CI) 5-year survival (CI)

Overall 7,965 7.3 (6.7, 8.0) 5.7 (5.2, 6.4) 52,312 7.7 (7.5, 8.0) 5.3 (5.1, 5.5)
Total Males 3,855 7.3 (6.4, 8.2) 5.6 (4.8, 6.5) 25,540 7.8 (7.4, 8.1) 5.1 (4.8, 5.5)
Total Females 4,110 7.4 (6.5, 8.3) 5.9 (5.1, 6.7) 26,772 7.7 (7.3, 8.0) 5.5 (5.2, 5.8)
Whites 6,063 7.6 (6.9, 8.3) 5.9 (5.2, 6.6) 42,815 7.7 (7.4, 8.0) 5.3 (5.0, 5.5)
   Male 2,995 7.4 (6.4, 8.5) 5.6 (4.7, 6.6) 21,138 7.8 (7.4, 8.2) 5.2 (4.8, 5.5)
   Female 3,068 7.7 (6.7, 8.8) 6.1 (5.2, 7.2) 21,677 7.6 (7.2, 8.0) 5.4 (5.0, 5.7)
Black 1,826 6.5 (5.3, 7.8) 5.3 (4.2, 6.6) 5,755 7.1 (6.4, 7.9) 5.0 (4.3, 5.8)
   Male 819 6.5 (4.9, 8.6) 5.5 (3.9, 7.5) 2,567 6.6 (5.5, 7.7) 4.1 (3.2, 5.2)
   Female 1,007 6.5 (4.9, 8.3) 5.2 (3.7, 6.9) 3,188 7.6 (6.6, 8.6) 5.7 (4.8, 6.8)

Subi Gandhi Journal of Cancer Therapeutics and Research  2017 6:3DOI : 10.7243/2049-7962-6-3